Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

SSE:603896.SS

22.31 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 170.805219.646119.452130.529220.902241.715171.142165.335206.156321.427158.115145.809203.72287.399162.246143.362174.13242.002157.827103.421132.8203.06489.2289.009165.466187.10997.367100.461126.515136.41666.51979.54187.487108.4757.56763.90384.94
Cost of Revenue 31.38541.41225.99736.63637.74441.0727.76232.74533.9552.79123.94122.87529.60143.34627.96926.93528.12336.88727.01717.71924.04730.99515.37214.74724.29327.12314.70513.40516.8317.24410.34411.09712.24314.3888.13711.13313.919
Gross Profit 139.421178.23393.45693.893183.158200.645143.379132.589172.206268.636134.174122.935174.119244.052134.278116.428146.007205.115130.8185.702108.753172.06973.84874.262141.172159.98582.66287.056109.685119.17256.17468.44475.24494.08249.43152.77171.02
Gross Profit Ratio 0.8160.8110.7820.7190.8290.830.8380.8020.8350.8360.8490.8430.8550.8490.8280.8120.8380.8480.8290.8290.8190.8470.8280.8340.8530.8550.8490.8670.8670.8740.8440.860.860.8670.8590.8260.836
Reseach & Development Expenses 11.90712.7718.6469.6611.4259.83713.28415.13311.4299.88511.00616.11710.81615.72213.4113.168.53217.0489.94310.2211.27312.0548.2579.1129.99713.6495.67220.1158.57832.2243.4876.228017.8105.0723.937
General & Administrative Expenses 20.229-25.35943.886-1.921.06-24.09247.080.90720.037-20.16543.638-3.80517.522-20.56337.020.49218.723-7.10715.6142.37722.746-23.40530.67915.82625.9733.04824.4080.84215.774-16.22511.2290.6849.335-20.7139.09313.44710.617
Selling & Marketing Expenses 68.43617.85195.32765.21190.8886.12665.60176.31588.75382.8964.0177.28695.18982.56977.72676.58482.87882.21173.81861.14646.84396.48527.74543.71165.71278.97947.40650.35459.7663.00236.92839.37339.2637.13634.08529.07438.498
SG&A 88.665-7.508139.21376.96111.9462.034112.68177.221108.7962.725107.64873.482112.7162.006114.74677.076101.60175.10489.43263.52269.58973.0858.42559.53791.68482.02771.81551.19675.53446.77748.15840.05848.59516.42343.17842.52149.116
Other Expenses -19.46112.66-72.5740.0530.177-1.586-0.6090.089-2.07544.152-25.29712.579-3.319-15.261-1.373-1.611-0.177-6.707-2.3870.171-1.19-0.755-0.512-1.5620.0491.924-2.176-0.0750.11-2.4740.433-0.8170.8131.5861.6244.5032.227
Operating Expenses 81.112121.74775.28486.62119.75297.0397.789109.425118.145116.76393.357102.178120.208116.918109.933106.77107.188116.13498.61881.99377.436104.74665.46277.22299.936112.36677.11974.47375.99981.60848.3353.36450.0155.2643.49143.21249.403
Operating Income 58.30856.48618.1717.27476.697116.82749.65327.84160.401149.19148.81423.66159.212116.54434.21215.04941.34988.1127.5159.4333.84968.60311.0414.69443.43648.0988.18417.9636.06240.499.40517.12123.82136.4244.51110.4619.616
Operating Income Ratio 0.3410.2570.1520.0560.3470.4830.290.1680.2930.4640.3090.1620.2910.4060.2110.1050.2370.3640.1740.0910.2550.3380.1240.0530.2630.2570.0840.1790.2850.2970.1410.2150.2720.3360.0780.1640.231
Total Other Income Expenses Net 0.061-0.329-0.4370.0530.177-1.586-0.394-0.1832.295-1.853-0.887-0.154-0.019-2.931-1.151-1.611-0.177-1.797-2.3870.22-1.19-0.755-0.444-1.5620.0491.924-2.176-0.0750.11-2.4740.433-0.8170.0471.5861.6244.5032.226
Income Before Tax 58.3756.15717.73424.18476.874115.24149.31627.65862.695147.33747.92723.50859.193113.61232.83913.43841.17286.31325.1289.60132.65967.84810.5283.13243.48650.0226.00917.88536.17238.0169.83816.30424.63337.9866.13514.96321.843
Income Before Tax Ratio 0.3420.2560.1480.1850.3480.4770.2880.1670.3040.4580.3030.1610.2910.3950.2020.0940.2360.3570.1590.0930.2460.3340.1180.0350.2630.2670.0620.1780.2860.2790.1480.2050.2820.350.1070.2340.257
Income Tax Expense -0.0040.113-0.0630.219-0.2570.1220.1910.0330.085-0.036-0.0340.4710.051-0.0321.168-0.325-0.0621.6030.4770.061-0.1520.960.297-0.3360.1782.370.0490.018-0.002-0.0690-0.005-0.015-0.011-0.0280.004-0.016
Net Income 58.37456.04417.79723.74377.13115.11949.12527.62562.61147.64748.1223.02358.994113.77532.05613.76341.23384.7124.6519.5432.81166.88810.2313.46943.30847.6525.9617.86736.17338.0849.83816.30924.64837.9976.16314.95921.859
Net Income Ratio 0.3420.2550.1490.1820.3490.4760.2870.1670.3040.4590.3040.1580.290.3960.1980.0960.2370.350.1560.0920.2470.3290.1150.0390.2620.2550.0610.1780.2860.2790.1480.2050.2820.350.1070.2340.257
EPS 0.290.280.090.120.390.590.250.140.330.770.320.150.30.750.220.0940.220.580.130.0670.180.470.0550.0250.240.340.0320.130.20.190.0540.160.180.370.0460.140.16
EPS Diluted 0.290.280.090.120.390.590.250.140.330.770.320.150.30.750.220.0940.220.580.130.0670.180.470.0550.0250.240.340.0320.130.20.190.0540.160.180.370.0460.140.16
EBITDA 61.70586.5921.43352.91381.569140.06881.85361.59797.192176.43873.5443.60678.751133.63952.87431.48360.07991.4341.14926.16448.27176.49519.31914.5175550.5076.21820.09936.22542.5427.84428.08933.40350.6615.9423.61730.525
EBITDA Ratio 0.3610.3940.1790.4050.3690.5790.4780.3730.4710.5490.4650.2990.3870.4650.3260.220.3450.3780.2610.2530.3630.3770.2170.1630.3320.270.0640.20.2860.3120.1180.3530.3820.4670.1030.370.359